| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anavex Life Sciences Corp. (AVXL) has 3 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. AVXL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 125.0K | $387.5K | - | |
| Other | 12.5K | $38.8K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2021 | Donhauser Peter D.O. | Director | Buy | 1,165 | $12.67 | $14,760.05 | +116.5% | -9.6% | -9.2% | |
| Mar 7, 2018 | Missling Christopher U | President And CEO | Buy | 1,360 | $2.92 | $3,971.20 | +0.1% | - | - | |
| Mar 6, 2018 | Missling Christopher U | President And CEO | Buy | 1,450 | $2.73 | $3,958.50 | +0.1% | - | - | |
| Mar 5, 2018 | Missling Christopher U | President And CEO | Buy | 1,500 | $2.63 | $3,945.00 | +0.1% | - | - | |
| Mar 2, 2018 | Missling Christopher U | Director, President &CEO | Buy | 1,650 | $2.41 | $3,976.50 | +0.2% | - | - | |
| Oct 25, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.39 | $1,646.25 | - | - | - | |
| Oct 24, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.92 | $1,845.00 | - | - | - | |
| Oct 19, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.49 | $1,683.75 | - | - | - | |
| Oct 17, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.27 | $1,601.25 | - | - | - | |
| Oct 13, 2017 | Missling Christopher U | President And CEO | Buy | 750 | $4.22 | $3,165.00 | - | - | - |